Strax

Autospela

Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas

14 Visningar • 07/18/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela